Abstract
AbstractTreating patients with COVID-19 is expensive, thus it is essential to identify factors on admission associated with hospital length of stay (LOS) and provide a risk assessment for clinical treatment. To address this, we conduct a retrospective study, which involved patients with laboratory-confirmed COVID-19 infection in Hefei, China and being discharged between January 20 2020 and March 16 2020. Demographic information, clinical treatment, and laboratory data for the participants were extracted from medical records. A prolonged LOS was defined as equal to or greater than the median length of hospitable stay. The median LOS for the 75 patients was 17 days (IQR 13–22). We used univariable and multivariable logistic regressions to explore the risk factors associated with a prolonged hospital LOS. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated. The median age of the 75 patients was 47 years. Approximately 75% of the patients had mild or general disease. The univariate logistic regression model showed that female sex and having a fever on admission were significantly associated with longer duration of hospitalization. The multivariate logistic regression model enhances these associations. Odds of a prolonged LOS were associated with male sex (aOR 0.19, 95% CI 0.05–0.63, p = 0.01), having fever on admission (aOR 8.27, 95% CI 1.47–72.16, p = 0.028) and pre-existing chronic kidney or liver disease (aOR 13.73 95% CI 1.95–145.4, p = 0.015) as well as each 1-unit increase in creatinine level (aOR 0.94, 95% CI 0.9–0.98, p = 0.007). We also found that a prolonged LOS was associated with increased creatinine levels in patients with chronic kidney or liver disease (p < 0.001). In conclusion, female sex, fever, chronic kidney or liver disease before admission and increasing creatinine levels were associated with prolonged LOS in patients with COVID-19.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Wu, D., Wu, T., Liu, Q. & Yang, Z. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 94, 44–48. https://doi.org/10.1016/j.ijid.2020.03.004 (2020).
2. WHO. Coronavirus disease (COVID-2019) situation reports-78. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200407-sitrep-78-covid-19.pdf?sfvrsn=bc43e1b_2 (2020).
3. Li, X. et al. Transmission dynamics and evolutionary history of 2019-nCoV. J. Med. Virol. 92, 501–511. https://doi.org/10.1002/jmv.25701 (2020).
4. Warwick, M. & Roshen, F. Economics in the Time of COVID-19 45–51 (Centre for Economic Policy Research, 2020).
5. Arshad Ali, S., Baloch, M., Ahmed, N., Arshad Ali, A. & Iqbal, A. The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat. J. Infect. Public Health https://doi.org/10.1016/j.jiph.2020.02.033 (2020).
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献